Advanced Search

Technical Analysis for RPTX - Repare Therapeutics Inc.

Grade Last Price % Change Price Change
grade F 25.15 -4.23% -1.11
RPTX closed down 4.23 percent on Friday, July 10, 2020, on 66 percent of normal volume. Note that the stock is in oversold territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a bounce should not be unexpected.
1 Watcher
Watchlist Portfolio

Trend Table & Recent Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Down
Historical RPTX trend table...
Date Alert Name Type % Chg
New 52 Week Closing Low Bearish 0.00%
Hot IPO Pullback Bullish Swing Setup 0.00%
Inside Day Range Contraction 0.00%
New 52 Week Closing Low Bearish -4.23%
Hot IPO Pullback Bullish Swing Setup -4.23%
New 52 Week Low Weakness -4.23%
Hot IPO Pullback Bullish Swing Setup -10.43%
Inside Day Range Contraction -10.43%
New 52 Week Closing Low Bearish -8.55%
Hot IPO Pullback Bullish Swing Setup -8.55%
Older EOD signals for RPTX ...
View Intraday Alerts

Free Daily (Stock) Chart Reading

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Read My Charts!
Configure default chart indicators Basic chart:

Profile

Repare Therapeutics is a leading precision oncology company enabled by its proprietary synthetic lethality approach to the discovery and development of novel therapeutics. The Company utilizes its genome-wide, CRISPR-enabled SNIPRx® platform to systematically discover and develop highly targeted cancer therapies focused on genomic instability, including DNA damage repair. The Company’s pipeline includes its lead product candidate RP-3500, a potential leading ATR inhibitor, as well as CCNE1-SL inhibitor and Polθ inhibitor programs.
Cancer Genetics Cancer Therapies

Is RPTX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Counts: 0 bullish, 1 bearish and 4 neutral indicators. You may wish to incorporate that into your trading strategies.

Recent News

Date Title
Jul 10 The Daily Biotech Pulse: Ziopharm Starts Blood Cancer Study, Allergan's Botox Gets Label Expansion, 3 IPOs
Jul 2 Leaf Group, Forma Therapeutics See Activist Action
Jul 2 The Daily Biotech Pulse: Novartis Settles Lawsuit For $678M, Sarepta In-Licenses Gene Therapy Pre-Treatment, Unity Biotech Outlines Second-Half Catalysts
Jun 23 Repare Therapeutics Announces Closing of Upsized Initial Public Offering and Exercise in Full of the Underwriters’ Option to Purchase Additional Shares
Jun 19 Repare Therapeutics prices upsized IPO at $20
Jun 19 Repare Therapeutics Announces Pricing of Upsized Initial Public Offering
Jun 17 Repare Therapeutics files for upsized IPO
Jun 15 Repare Therapeutics sets terms for IPO
See more RPTX news...

Indicators

Indicator Value
52 Week High 34.0
52 Week Low 25.01
Average Volume 256,513
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 0.00
10-Day Moving Average 29.01
Average True Range 2.00
ADX 0.0
+DI 2.16
-DI 33.18
Chandelier Exit (Long, 3 ATRs ) 28.00
Chandelier Exit (Short, 3 ATRs ) 31.01
Upper Bollinger Band 0.00
Lower Bollinger Band 0.00
Percent B (%b) 0.0
BandWidth 0.00
MACD Line -1.12
MACD Signal Line -0.43
MACD Histogram -0.6845
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 26.72
Resistance 3 (R3) 26.87 26.48 26.46
Resistance 2 (R2) 26.48 26.08 26.41 26.37
Resistance 1 (R1) 25.82 25.83 25.62 25.67 26.29
Pivot Point 25.43 25.43 25.34 25.36 25.43
Support 1 (S1) 24.77 25.03 24.58 24.63 24.01
Support 2 (S2) 24.38 24.78 24.31 23.93
Support 3 (S3) 23.72 24.38 23.84
Support 4 (S4) 23.58